VCT Share Price Performance
UK£6.40
-2.12 (-24.88%)
5.2% undervalued intrinsic discount
UK£6.75
Fair Value
Price UK£6.40
AnalystLowTarget UK£6.75
AnalystHighTarget UK£11.00
AnalystConsensusTarget UK£8.11
Fair ValueUK£6.75
Share Pricen/a
Victrex plc Stock Price
- 3 Narratives written by author
- 0 Comments on narratives written by author
- 24 Fair Values set on narratives written by author
VCT Community Narratives
AN
Fair Value UK£6.75 5.2% undervalued intrinsic discount
Circular Economy Risks Will Overturn Margins While Select Sectors Recover
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AN
Fair Value UK£11 41.8% undervalued intrinsic discount
High-performance Polymers Will Drive EV, Aerospace And Medical Expansion
1users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AN
Fair Value UK£8.11 n/aintrinsic discount
China Plant And Magma Programme Will Expand Market Reach
0users have liked this narrative
0users have commented on this narrative
10users have followed this narrative
China Plant And Magma Programme Will Expand Market Reach
Key Takeaways Initiatives like Project Vista and the new China plant aim to improve sales strategies and expand geographically, enhancing margins and growth potential. Magma mega-programme and Medical segment recovery are set to drive long-term volume increases and enhance revenue and margins.Read more
0users have liked this narrative
0users have commented on this narrative
10users have followed this narrative
AN
UK£8.11
n/aintrinsic discount
AnalystConsensusTarget Fair Value
Revenue growth
3.03% p.a.
Profit Margin
17.63%
Future PE
15.38x
Share price in 2028
UK£10.13
High-performance Polymers Will Drive EV, Aerospace And Medical Expansion
Key Takeaways Expansion in China and innovative digital tools could significantly outpace current growth and margin expectations through rapid market share gains and operational efficiencies. Rising demand for advanced polymers positions the company to secure higher volumes and pricing, while new downstream products boost margins and accelerate profit growth.Read more
1users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AN
UK£11
41.8% undervalued intrinsic discount
AnalystHighTarget Fair Value
Revenue growth
5.4% p.a.
Profit Margin
21.31%
Future PE
16.05x
Share price in 2028
UK£13.69
Circular Economy Risks Will Overturn Margins While Select Sectors Recover
Key Takeaways Shifts toward sustainable materials and increased regulatory scrutiny threaten demand, profitability, and market access for Victrex's traditional polymer products. Operational challenges, supply chain risks, and market pressure from low-cost competitors are compressing margins and undermining growth initiatives.Read more
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AN
UK£6.75
5.2% undervalued intrinsic discount
AnalystLowTarget Fair Value
Revenue growth
2.86% p.a.
Profit Margin
16.63%
Future PE
13.56x
Share price in 2028
UK£8.39
Snowflake Analysis
Victrex plc Key Details
Last Reported Earnings
Mar 31, 2025
Next Reporting Earnings
Dec 02, 2025
- 0.34
- 42.64%
- 9.98%
- 13.0%
About VCT
- Founded
- 1993
- Employees
- 1131
- CEO
- WebsiteView website
Victrex plc, through its subsidiaries, engages in the manufacture and sale of polymer solutions worldwide. The company operates through two segments, Sustainable Solutions and Medical. It develops PEEK and PAEK based polymer solutions, and semi-finished and finished parts. The company also provides specialist solutions for medical device manufacturers; sells thermoplastic polymers; sustainable solutions for energy and industrial, VAR, aerospace, automotive, and electronics markets; and engages in trading activities. It serves automotive, aerospace, energy and industrial, electronics, and medical markets. Victrex plc was incorporated in 1993 and is headquartered in Thornton-Cleveleys, the United Kingdom.
